Skip to main content

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link



Dow Jones Industrial Average



) is trading down 46.0 points (-0.3%) at 14,794 as of Friday, Aug 30, 2013, 11:35 a.m. ET. During this time, 149.7 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 538.4 million. The NYSE advances/declines ratio sits at 867 issues advancing vs. 1,988 declining with 120 unchanged.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Holding back the Dow today is



Scroll to Continue

TheStreet Recommends


), which is lagging the broader Dow index with a five-cent decline (-0.6%) bringing the stock to $7.76. This single loss is lowering the Dow Jones Industrial Average by 0.38 points or roughly accounting for 0.8% of the Dow's overall loss. Volume for Alcoa currently sits at 13.6 million shares traded vs. an average daily trading volume of 17.2 million shares.

Alcoa has a market cap of $8.48 billion and is part of the basic materials sector and metals & mining industry. Shares are down 8.6% year to date as of Thursday's close. The stock's dividend yield sits at 1.5%.

Alcoa Inc. engages in the production and management of primary aluminum, fabricated aluminum, and alumina. The company operates in four segments: Alumina, Primary Metals, Global Rolled Products, and Engineered Products and Solutions.

TheStreet Ratings rates Alcoa as a


. Among the primary strengths of the company is its respectable return on equity which we feel is likely to continue. At the same time, however, we also find weaknesses including unimpressive growth in net income, poor profit margins and weak operating cash flow.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more